COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica completes acquisition of Optegra
01/10/2025
EssilorLuxottica completes acquisition of Optegra Paris, France (1 October 2025) – EssilorLuxottica announces that it has successfully completed the acquisition of Optegra from MidEuropa. Under the Optegra, Lexum and [...]
Elixir Medical Announces Key Commercial Milestone With LithiX™ Hertz Contact (HC) Intravascular Lithotripsy System (IVL)
01/10/2025
LithiX™ HC-IVL is a novel lithotripsy system designed to facilitate treatment of heart disease exacerbated by the presence of calcium within coronary artery plaques New clinical study to be presented at Transcatheter [...]
Visory Health Delivers $790 Million in Savings on Critical Cardiovascular Medications
01/10/2025
Benefiting over 1.5 million cardiovascular patients, prescription discount cards help reduce a key financial barrier potentially preventing thousands of heart attacks and strokes annually ESTERO, Fla., Oct. 01, 2025 ( [...]
CJ Biomaterials launches new PHA platform for extrusion coatings in repulpable and home compostable food serviceware and food packaging applications
01/10/2025
PHACT™ PHA semi-crystalline and amorphous grades combine to create PHA extrusion coatings that deliver excellent paper adhesion, sealing performance, and oil and grease resistance in a coating that sets the [...]
Positron Corporation Wins Innovation Award in PET-CT Category from Medical Device Network’s Excellence Awards 2025
01/10/2025
Buffalo, NY, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced that it has won the Innovation Award [...]
Palisade Bio Announces Pricing of Upsized $120 Million Underwritten Public Offering of Common Stock
01/10/2025
Carlsbad, CA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for [...]
Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology
01/10/2025
SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care SOUTH JORDAN, Utah, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of [...]
Cellphire Therapeutics announces CRYPTICS Phase 2/3 Clinical Study Final Topline Results
01/10/2025
CRYPTICS study met the primary efficacy endpoint measure, 24-hour chest tube drainage (Difference in LS Means was 142.0 mL; 95.576% confidence interval of volume difference lower than noninferiority margin) Sensitivity [...]
USOSM Enables Significant Growth for Partners
01/10/2025
10 Surgeons Join Affiliated Practices in Six States IRVING, Texas, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Ten oral and maxillofacial surgeons have joined U.S. Oral Surgery Management ( USOSM ) partner practices in six states [...]
Human Appeal Launches Birmingham’s First ‘Third Space’ Community Hub in Sparkhill
01/10/2025
BIRMINGHAM, United Kingdom, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Human Appeal, one of the UK’s leading humanitarian aid charities, today announces the launch of its first-ever community hub in Birmingham, ‘The Third Space [...]
IntusCare Announces Major Implementation Milestone for CareHub EMR, Achieving Successful Go-Lives Across Diverse PACE Programs
01/10/2025
IntusCare’s milestone highlights how CareHub empowers PACE teams to deliver smarter, compliant, and participant-centered care from day one. Providence, Rhode Island, Oct. 01, 2025 (GLOBE NEWSWIRE) -- IntusCare , a [...]
Health-ISAC® Marks 15 Years of Protecting the Global Health Sector
01/10/2025
ORLANDO, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Health-ISAC (Health Information Sharing and Analysis Center), a trusted community that is the go-to source of timely, actionable, and relevant information for the global [...]
Folia Health Secures $10.5M in Funding to Transform Healthcare and Research With Patient-Reported Information
01/10/2025
Series A investment will advance the company’s efforts to give patients the power to drive research on rare diseases and chronic conditions BOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Folia Health , the patient-driven [...]
OPA: Compromising Safety in the Name of Access
01/10/2025
TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Ontario’s mental health system is already under immense pressure, and the Ontario Psychological Association (OPA) warns that lowering professional standards will only make [...]
Her Natural Edge and In Her Corner Launch Conversational AI Companions to Support Menopause Awareness
01/10/2025
Alexandria, VA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Her Natural Edge and In Her Corner announced the launch of Valerie and Jordan, two conversational voice companions developed to provide information and support around [...]
Arvinas to Present Clinical Data for ARV-102, a PROTAC LRRK2 Degrader, at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®
01/10/2025
NEW HAVEN, Conn., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that two [...]
Comphya Announces First Patient Implanted with CaverSTIM in U.S. Pilot Study at Johns Hopkins University School of Medicine
01/10/2025
Pilot study evaluates safety and tolerability of implantable neuromodulation therapy for erectile dysfunction following radical prostatectomy LAUSANNE, Switzerland, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Comphya SA, a [...]
Spur Therapeutics to Present New Clinical Data on Its Gene Therapy Candidate in Gaucher Disease at Upcoming ESGCT Annual Congress
01/10/2025
LONDON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced it will present new clinical data for avigbagene parvec (FLT201), its Phase 3-ready gene therapy candidate for Gaucher disease, at the European [...]
Kura Oncology and Kyowa Kirin Launch Clinical Trial Evaluating Dual Inhibition of NPM1 and FLT3 Mutations in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
01/10/2025
– Expanding clinical experience and safety profile of ziftomenib support its evaluation in combination with approved FLT3 inhibitors in frontline AML – – FLT3 mutations occur in approximately 30% of newly diagnosed [...]

Pages